Weight loss with glucagon ‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
We report a patient with BBS who underwent successful weight reduction through the use of glucagon-like peptide-1 receptor agonists.
Source: Clinical Obesity - Category: Eating Disorders & Weight Management Authors: Shawg Ganawa,
Smrithi Hema Santhosh,
Lucy Parry,
Akheel A. Syed Tags: CASE REPORT Source Type: research
More News: Cardiology | Coronary Heart Disease | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Genetics | Heart | Heart Disease | Men | Metabolic Syndrome | Obesity | Weight Loss